Announcing a new publication for Acta Materia Medica journal. Proteolysis targeting chimeras (PROTACs), as a novel therapeutic drug model, has received widespread attention from academia and the ...
This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...
Intellomx Launches Swarm-Based AI Platform to Accelerate and De-Risk Novel Target and Drug Discovery
Intellomx announces its' new Pilot platform, delivering rapid identification of novel drugs arising from its therapeutic target identification capability. Intellomx now offers an end-to-end AI ...
A new iPSC-derived cellular tool with built-in Cas9 expression enables high efficiency knockout screening for drug target identification and validation. Functional genomics screening that leverages ...
Neurodegenerative disorders are defined by progressive neuronal dysfunction and death, in which oxidative stress is recognized as a central contributor to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results